Archived from the original on 15 May 2024
That conversation benefits from a provider who works with these medications daily and has clinical experience with exactly that situation, rather than a generalist physician fitting a GLP-1 consult in between other types of appointments
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test reveals individual predispositions in GLP-1 receptor pathways (GLP1R rs6923761) and metabolic markers (FTO rs9939609, MC4R rs17782313) that may help provide context for how your body responds to GLP-1 medication and manages metabolic stress
Participants receiving semaglutide also lost an average of 10.5% of their body weight, creating an important mechanistic question: how much of the liver benefit came from weight loss, and how much came from GLP-1 signaling within the liver
The placebo group lost just 2.2 percent
Ozempic face describes facial volume loss from fat reduction a cosmetic consequence of weight loss, not a drug toxicity